Amedeo Smart

Free Medical Literature Service



Liver Diseases

  Free Subscription

Articles published in
Eur Radiol
    August 2022
  1. NALLET C, Pazart L, Cochet C, Vidal C, et al
    Prenatal quantification of human foetal lung and liver elasticities between 24 and 39 weeks of gestation using 2D shear wave elastography.
    Eur Radiol. 2022;32:5559-5567.
    >> Share

  2. HONG S, Choi SH, Hong SB, Kim SY, et al
    Clinical usefulness of multiple arterial-phase images in gadoxetate disodium-enhanced magnetic resonance imaging: a systematic review and meta-analysis.
    Eur Radiol. 2022;32:5413-5423.
    >> Share

    July 2022
  3. KIM TH, Lee JM, Lee DH, Joo I, et al
    Can "no-touch" radiofrequency ablation for hepatocellular carcinoma improve local tumor control? Systematic review and meta-analysis.
    Eur Radiol. 2022 Jul 30. pii: 10.1007/s00330-022-08991.
    >> Share

  4. OCAL O, Zech CJ, Fabritius MP, Loewe C, et al
    Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progression.
    Eur Radiol. 2022 Jul 26. pii: 10.1007/s00330-022-09000.
    >> Share

  5. CHEN BB, Liang PC, Shih TT, Liu TH, et al
    Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma.
    Eur Radiol. 2022 Jul 21. pii: 10.1007/s00330-022-08980.
    >> Share

  6. KIM YY, Lee S, Shin J, Son WJ, et al
    Diagnostic performance of CT versus MRI Liver Imaging Reporting and Data System category 5 for hepatocellular carcinoma: a systematic review and meta-analysis of comparative studies.
    Eur Radiol. 2022 Jul 18. pii: 10.1007/s00330-022-08985.
    >> Share

  7. CHOI SJ, Choi SH, Lee DY, Lee JS, et al
    Diagnostic value of [(68) Ga]Ga-DOTA-labeled-somatostatin analogue PET/MRI for detecting liver metastasis in patients with neuroendocrine tumors: a systematic review and meta-analysis.
    Eur Radiol. 2022;32:4628-4637.
    >> Share

  8. ZHU HD, Li X, Ji JS, Huang M, et al
    TACE with dicycloplatin in patients with unresectable hepatocellular carcinoma: a multicenter randomized phase II trial.
    Eur Radiol. 2022 Jul 1. pii: 10.1007/s00330-022-08848.
    >> Share

    June 2022
  9. DIMOV IP, Tous C, Li N, Barat M, et al
    Assessment of hepatic arterial hemodynamics with 4D flow MRI: in vitro analysis of motion and spatial resolution related error and in vivo feasibility study in 20 volunteers.
    Eur Radiol. 2022 Jun 22. pii: 10.1007/s00330-022-08890.
    >> Share

  10. KENNEDY P, Stocker D, Carbonell G, Said D, et al
    MR elastography outperforms shear wave elastography for the diagnosis of clinically significant portal hypertension.
    Eur Radiol. 2022 Jun 21. pii: 10.1007/s00330-022-08935.
    >> Share

  11. HWANG JA, Jeong WK, Kang HJ, Lee ES, et al
    Perfluorobutane-enhanced ultrasonography with a Kupffer phase: improved diagnostic sensitivity for hepatocellular carcinoma.
    Eur Radiol. 2022 Jun 16. pii: 10.1007/s00330-022-08900.
    >> Share

  12. JIAO CY, Zhang H, Ji GW, Xu Q, et al
    CT-based clinico-radiological nomograms for prognosis prediction in patients with intrahepatic mass-forming cholangiocarcinoma: a multi-institutional study.
    Eur Radiol. 2022 Jun 16. pii: 10.1007/s00330-022-08914.
    >> Share

  13. PENG Y, Shen H, Tang H, Huang Y, et al
    Nomogram based on CT-derived extracellular volume for the prediction of post-hepatectomy liver failure in patients with resectable hepatocellular carcinoma.
    Eur Radiol. 2022 Jun 9. pii: 10.1007/s00330-022-08917.
    >> Share

  14. DE COBELLI F, Calandri M, Della Corte A, Sirovich R, et al
    Multi-institutional analysis of outcomes for thermosphere microwave ablation treatment of colorectal liver metastases: the SMAC study.
    Eur Radiol. 2022;32:4147-4159.
    >> Share

  15. ZHANG K, Xie SS, Li WC, Ye ZX, et al
    Prediction of microvascular invasion in HCC by a scoring model combining Gd-EOB-DTPA MRI and biochemical indicators.
    Eur Radiol. 2022;32:4186-4197.
    >> Share

    May 2022
  16. HUANG Z, Zhou P, Li S, Li K, et al
    Evaluation of contrast-enhanced ultrasound LI-RADS version 2017: application on 271 liver nodules in individuals with non-alcoholic steatohepatitis.
    Eur Radiol. 2022 May 31. pii: 10.1007/s00330-022-08872.
    >> Share

  17. MENG D, Liang C, Zheng Y, Wang X, et al
    The value of gadobenate dimeglumine-enhanced biliary imaging from the hepatobiliary phase for predicting post-hepatectomy liver failure in HCC patients.
    Eur Radiol. 2022 May 31. pii: 10.1007/s00330-022-08874.
    >> Share

  18. TAGO K, Tsukada J, Sudo N, Shibutani K, et al
    Comparison between CT volumetry and extracellular volume fraction using liver dynamic CT for the predictive ability of liver fibrosis in patients with hepatocellular carcinoma.
    Eur Radiol. 2022 May 20. pii: 10.1007/s00330-022-08852.
    >> Share

  19. PAN J, Li W, Gu L, Liu C, et al
    Performance of adding hepatobiliary phase image in magnetic resonance imaging for detection of hepatocellular carcinoma: a meta-analysis.
    Eur Radiol. 2022 May 17. pii: 10.1007/s00330-022-08826.
    >> Share

  20. WEI H, Jiang H, Qin Y, Wu Y, et al
    Comparison of a preoperative MR-based recurrence risk score versus the postoperative score and four clinical staging systems in hepatocellular carcinoma: a retrospective cohort study.
    Eur Radiol. 2022 May 13. pii: 10.1007/s00330-022-08811.
    >> Share

  21. HEO S, Kim DW, Choi SH, Kim SW, et al
    Diagnostic performance of liver fibrosis assessment by quantification of liver surface nodularity on computed tomography and magnetic resonance imaging: systematic review and meta-analysis.
    Eur Radiol. 2022;32:3377-3387.
    >> Share

  22. SHIN J, Lee S, Hwang JA, Lee JE, et al
    MRI-diagnosis of category LR-M observations in the Liver Imaging Reporting and Data System v2018: a systematic review and meta-analysis.
    Eur Radiol. 2022;32:3319-3326.
    >> Share

  23. TANG A, Dzyubak B, Yin M, Schlein A, et al
    MR elastography in nonalcoholic fatty liver disease: inter-center and inter-analysis-method measurement reproducibility and accuracy at 3T.
    Eur Radiol. 2022;32:2937-2948.
    >> Share

  24. PARK S, Yoon JH, Joo I, Yu MH, et al
    Image quality in liver CT: low-dose deep learning vs standard-dose model-based iterative reconstructions.
    Eur Radiol. 2022;32:2865-2874.
    >> Share

  25. GHADIMI M, Birnbaum J, Kamel IR, Sirlin CB, et al
    What proportion of LI-RADS 5 observations reported in clinical practice do not meet LI-RADS 5 criteria?
    Eur Radiol. 2022;32:3327-3333.
    >> Share

    April 2022
  26. QIU Z, Wang G, Yan H, Qi H, et al
    TIPS plus sequential systemic therapy of advanced HCC patients with tumour thrombus-related symptomatic portal hypertension.
    Eur Radiol. 2022 Apr 20. pii: 10.1007/s00330-022-08705.
    >> Share

  27. ZHANG W, Wang J, Linghu R, Chen X, et al
    Correction to: Comparison between spleen and liver stiffness measurements by sound touch elastography for diagnosing cirrhosis at different aminotransferase levels: a prospective multicenter study.
    Eur Radiol. 2022 Apr 12. pii: 10.1007/s00330-022-08727.
    >> Share

  28. MULLER L, Kloeckner R, Mahringer-Kunz A, Stoehr F, et al
    Fully automated AI-based splenic segmentation for predicting survival and estimating the risk of hepatic decompensation in TACE patients with HCC.
    Eur Radiol. 2022 Apr 8. pii: 10.1007/s00330-022-08737.
    >> Share

  29. WANG X, Tan Y, Liu D, Shen H, et al
    Chemotherapy-associated steatohepatitis was concomitant with epicardial adipose tissue volume increasing in breast cancer patients who received neoadjuvant chemotherapy.
    Eur Radiol. 2022 Apr 8. pii: 10.1007/s00330-022-08581.
    >> Share

  30. XIA D, Wang Q, Bai W, Wang E, et al
    Optimal time point of response assessment for predicting survival is associated with tumor burden in hepatocellular carcinoma receiving repeated transarterial chemoembolization.
    Eur Radiol. 2022 Apr 6. pii: 10.1007/s00330-022-08716.
    >> Share

  31. LEE T, Lee JM, Yoon JH, Joo I, et al
    Deep learning-based image reconstruction of 40-keV virtual monoenergetic images of dual-energy CT for the assessment of hypoenhancing hepatic metastasis.
    Eur Radiol. 2022 Apr 5. pii: 10.1007/s00330-022-08728.
    >> Share

  32. ZHANG YN, Fowler KJ, Boehringer AS, Montes V, et al
    Comparative diagnostic performance of ultrasound shear wave elastography and magnetic resonance elastography for classifying fibrosis stage in adults with biopsy-proven nonalcoholic fatty liver disease.
    Eur Radiol. 2022;32:2457-2469.
    >> Share

  33. DOEMEL LA, Santana JG, Savic LJ, Gaupp FML, et al
    Comparison of metabolic and immunologic responses to transarterial chemoembolization with different chemoembolic regimens in a rabbit VX2 liver tumor model.
    Eur Radiol. 2022;32:2437-2447.
    >> Share

  34. BENOIT C, Rodrigues A, Calderaro J, Charpy C, et al
    Autofluorescence imaging within the liver: a promising tool for the detection and characterization of primary liver tumors.
    Eur Radiol. 2022;32:2481-2491.
    >> Share

    March 2022
  35. YOUN SY, Kim B, Kim DH, Choi HJ, et al
    Liver Imaging-Reporting and Data System treatment response algorithm predicts postsurgical recurrence in locoregional therapy-treated hepatocellular carcinoma.
    Eur Radiol. 2022 Mar 29. pii: 10.1007/s00330-022-08720.
    >> Share

  36. WANG Y, Zhu GQ, Zhou CW, Li N, et al
    Risk stratification of LI-RADS M and LI-RADS 4/5 combined hepatocellular cholangiocarcinoma: prognostic values of MR imaging features and clinicopathological factors.
    Eur Radiol. 2022 Mar 22. pii: 10.1007/s00330-022-08691.
    >> Share

  37. SHENG R, Huang X, Jin K, Gao S, et al
    Contrast-enhanced MRI could predict response of systemic therapy in advanced intrahepatic cholangiocarcinoma.
    Eur Radiol. 2022 Mar 17. pii: 10.1007/s00330-022-08679.
    >> Share

  38. LUO N, Huang X, Ji Y, Jin G, et al
    A functional liver imaging score for preoperative prediction of liver failure after hepatocellular carcinoma resection.
    Eur Radiol. 2022 Mar 16. pii: 10.1007/s00330-022-08656.
    >> Share

  39. PAN J, Tao Y, Chi X, Yang L, et al
    Do transition and hepatobiliary phase hypointensity improve LI-RADS categorization as an alternative washout: a systematic review and meta-analysis.
    Eur Radiol. 2022 Mar 10. pii: 10.1007/s00330-022-08665.
    >> Share

  40. YOON JK, Choi JY, Rhee H, Park YN, et al
    MRI features of histologic subtypes of hepatocellular carcinoma: correlation with histologic, genetic, and molecular biologic classification.
    Eur Radiol. 2022 Mar 8. pii: 10.1007/s00330-022-08643.
    >> Share

  41. KONG J, Gao R, Wu S, Shi Y, et al
    Correction to: Safety and efficacy of microwave versus radiofrequency ablation for large hepatic hemangioma: a multicenter retrospective study with propensity score matching.
    Eur Radiol. 2022 Mar 3. pii: 10.1007/s00330-022-08634.
    >> Share

  42. COSTANTINO A, Piagnani A, Nandi N, Sciola V, et al
    Reproducibility and diagnostic accuracy of pocket-sized ultrasound devices in ruling out compensated cirrhosis of mixed etiology.
    Eur Radiol. 2022 Mar 3. pii: 10.1007/s00330-022-08572.
    >> Share

  43. YAN Y, Xing X, Wang X, Yang L, et al
    Liver stiffness by two-dimensional shear wave elastography for screening high-risk varices in patients with compensated advanced chronic liver disease.
    Eur Radiol. 2022;32:2078-2088.
    >> Share

  44. BOS D, Yu S, Luong J, Chu P, et al
    Diagnostic reference levels and median doses for common clinical indications of CT: findings from an international registry.
    Eur Radiol. 2022;32:1971-1982.
    >> Share

  45. WANG Q, Wang A, Sparrelid E, Zhang J, et al
    Predictive value of gadoxetic acid-enhanced MRI for posthepatectomy liver failure: a systematic review.
    Eur Radiol. 2022;32:1792-1803.
    >> Share

  46. CANNELLA R, Vernuccio F, Antonucci M, Gagliano DS, et al
    LI-RADS ancillary features favoring benignity: is there a role in LR-5 observations?
    Eur Radiol. 2022;32:1804-1812.
    >> Share

  47. DIOGUARDI BURGIO M, Sartoris R, Beaufrere A, Gregory J, et al
    Liver surface nodularity on non-contrast MRI identifies advanced fibrosis in patients with NAFLD.
    Eur Radiol. 2022;32:1781-1791.
    >> Share

    Refining imaging tools to detect advanced fibrosis: could liver surface nodularity address an unmet need in the NAFLD epidemic?
    Eur Radiol. 2022;32:1757-1759.
    >> Share

  49. LUDEMANN W, Kahn J, Pustelnik D, Hardt J, et al
    Yttrium-90 radioembolization for unresectable hepatocellular carcinoma: predictive modeling strategies to anticipate tumor response and improve patient selection.
    Eur Radiol. 2022 Mar 1. pii: 10.1007/s00330-022-08585.
    >> Share

    February 2022
  50. ZHANG W, Wang J, Linghu R, Chen X, et al
    Comparison between spleen and liver stiffness measurements by sound touch elastography for diagnosing cirrhosis at different aminotransferase levels: a prospective multicenter study.
    Eur Radiol. 2022 Feb 28. pii: 10.1007/s00330-022-08569.
    >> Share

  51. PARK HJ, Lee TY, Kim SY, Kim MJ, et al
    Hypervascular transformation of hepatobiliary phase hypointense nodules without arterial phase hyperenhancement on gadoxetic acid-enhanced MRI: long-term follow-up in a surveillance cohort.
    Eur Radiol. 2022 Feb 28. pii: 10.1007/s00330-022-08623.
    >> Share

  52. LIU Y, Tan HY, Zhang XG, Zhen YH, et al
    Prediction of high-risk esophageal varices in patients with chronic liver disease with point and 2D shear wave elastography: a systematic review and meta-analysis.
    Eur Radiol. 2022 Feb 15. pii: 10.1007/s00330-022-08601.
    >> Share

  53. LI M, Yin Z, Hu B, Guo N, et al
    MR Elastography-Based Shear Strain Mapping for Assessment of Microvascular Invasion in Hepatocellular Carcinoma.
    Eur Radiol. 2022 Feb 11. pii: 10.1007/s00330-022-08578.
    >> Share

  54. SERBANESCU-KELE APOR DE ZALAN , Ruiter SJS, van den Berg AP, Pennings JP, et al
    Outcomes after primary and repeat thermal ablation of hepatocellular carcinoma with or without liver transplantation.
    Eur Radiol. 2022 Feb 8. pii: 10.1007/s00330-021-08515.
    >> Share

  55. ZHOU Y, Zhou G, Zhang J, Xu C, et al
    DCE-MRI based radiomics nomogram for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma.
    Eur Radiol. 2022 Feb 7. pii: 10.1007/s00330-022-08548.
    >> Share

  56. XIONG J, Luo J, Bian J, Wu J, et al
    Overall diagnostic accuracy of different MR imaging sequences for detection of dysplastic nodules: a systematic review and meta-analysis.
    Eur Radiol. 2022;32:1285-1296.
    >> Share

  57. LI X, Qi Z, Du H, Geng Z, et al
    Deep convolutional neural network for preoperative prediction of microvascular invasion and clinical outcomes in patients with HCCs.
    Eur Radiol. 2022;32:771-782.
    >> Share

  58. MIN JH, Kim JM, Kim YK, Kim H, et al
    A modified LI-RADS: targetoid tumors with enhancing capsule can be diagnosed as HCC instead of LR-M lesions.
    Eur Radiol. 2022;32:912-922.
    >> Share

  59. SUN C, Zhang X, Chen X, Zhu T, et al
    Single-direction diffusion-weighted imaging may be a simple complementary sequence for evaluating fetal corpus callosum.
    Eur Radiol. 2022;32:1135-1143.
    >> Share

    January 2022
  60. ZHENG H, Liu K, Yang Y, Liu B, et al
    Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study.
    Eur Radiol. 2022 Jan 29. pii: 10.1007/s00330-022-08537.
    >> Share

  61. KONG J, Gao R, Wu S, Shi Y, et al
    Safety and efficacy of microwave versus radiofrequency ablation for large hepatic hemangioma: a multicenter retrospective study with propensity score matching.
    Eur Radiol. 2022 Jan 29. pii: 10.1007/s00330-021-08425.
    >> Share

  62. KELAHAN LC, Kim D, Soliman M, Avery RJ, et al
    Role of hepatic metastatic lesion size on inter-reader reproducibility of CT-based radiomics features.
    Eur Radiol. 2022 Jan 26. pii: 10.1007/s00330-021-08526.
    >> Share

  63. DONG SY, Wang WT, Chen XS, Yang YT, et al
    Microvascular invasion of small hepatocellular carcinoma can be preoperatively predicted by the 3D quantification of MRI.
    Eur Radiol. 2022 Jan 25. pii: 10.1007/s00330-021-08495.
    >> Share

  64. YOUNG S, Chen T, Flanagan S, Golzarian J, et al
    Realized tumor to normal ratios in hepatocellular carcinoma patients undergoing transarterial radioembolization: a retrospective evaluation.
    Eur Radiol. 2022 Jan 15. pii: 10.1007/s00330-021-08501.
    >> Share

  65. SUN SH, Eche T, Dorczynski C, Otal P, et al
    Predicting death or recurrence of portal hypertension symptoms after TIPS procedures.
    Eur Radiol. 2022 Jan 11. pii: 10.1007/s00330-021-08437.
    >> Share

  66. LIU C, Shen Z, Ma H, Wang X, et al
    Gd-BOPTA-enhanced hepatobiliary phase MR imaging can predict the prognosis of patients with acute-on-chronic liver failure.
    Eur Radiol. 2022 Jan 6. pii: 10.1007/s00330-021-08440.
    >> Share

  67. WACKENTHALER A, Moliere S, Artzner T, Michard B, et al
    Pre-operative CT scan helps predict outcome after liver transplantation for acute-on-chronic grade 3 liver failure.
    Eur Radiol. 2022;32:12-21.
    >> Share

  68. JEON SK, Joo I, Bae JS, Park SJ, et al
    LI-RADS v2018: how to appropriately use ancillary features in category adjustment from intermediate probability of malignancy (LR-3) to probably HCC (LR-4) on gadoxetic acid-enhanced MRI.
    Eur Radiol. 2022;32:46-55.
    >> Share

    December 2021
  69. AUER TA, Fehrenbach U, Grieser C, Penzkofer T, et al
    Correction to: Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?
    Eur Radiol. 2021 Dec 5. pii: 10.1007/s00330-021-08386.
    >> Share

  70. GHANI MA, Fereydooni A, Chen E, Letzen B, et al
    Identifying enhancement-based staging markers on baseline MRI in patients with colorectal cancer liver metastases undergoing intra-arterial tumor therapy.
    Eur Radiol. 2021;31:8858-8867.
    >> Share

  71. LI M, Yang H, Liu Y, Zhang L, et al
    Comparison of the diagnostic performance of 2D and 3D MR elastography in staging liver fibrosis.
    Eur Radiol. 2021;31:9468-9478.
    >> Share

  72. YIN Y, Yakar D, Dierckx RAJO, Mouridsen KB, et al
    Liver fibrosis staging by deep learning: a visual-based explanation of diagnostic decisions of the model.
    Eur Radiol. 2021;31:9620-9627.
    >> Share

  73. SCHEGERER AA, Frija G, Paulo G, Jaschke W, et al
    Radiation dose and diagnostic reference levels for four interventional radiology procedures: results of the prospective European multicenter survey EUCLID.
    Eur Radiol. 2021;31:9346-9360.
    >> Share

    November 2021
    Editorial comment: advances in the evaluation of liver imaging and function with gadoxetic acid-enhanced MRI.
    Eur Radiol. 2021;31:8374-8375.
    >> Share

  75. MARKICH R, Palussiere J, Catena V, Cazayus M, et al
    Radiomics complements clinical, radiological, and technical features to assess local control of colorectal cancer lung metastases treated with radiofrequency ablation.
    Eur Radiol. 2021;31:8302-8314.
    >> Share

  76. QU Y, Middleton MS, Loomba R, Glaser KJ, et al
    Magnetic resonance elastography biomarkers for detection of histologic alterations in nonalcoholic fatty liver disease in the absence of fibrosis.
    Eur Radiol. 2021;31:8408-8419.
    >> Share

  77. FAN W, Guo J, Zhu B, Wang S, et al
    Drug-eluting beads TACE is safe and non-inferior to conventional TACE in HCC patients with TIPS.
    Eur Radiol. 2021;31:8291-8301.
    >> Share

  78. HAM JH, Yu JS, Choi JM, Cho ES, et al
    Corona enhancement can substitute enhancing capsule in the imaging diagnosis of small (
    Eur Radiol. 2021;31:8628-8637.
    >> Share

  79. LU X, Zhou H, Wang K, Jin J, et al
    Comparing radiomics models with different inputs for accurate diagnosis of significant fibrosis in chronic liver disease.
    Eur Radiol. 2021;31:8743-8754.
    >> Share

    October 2021
  80. YANG J, Huang JY, Chen X, Ling WW, et al
    Correction to: Combined hepatocellular-cholangiocarcinoma: can we use contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) to predict the patient's survival?

    Eur Radiol. 2021 Oct 14. pii: 10.1007/s00330-021-08256.
    >> Share

  81. BARGELLINI I, Lorenzoni V, Lorenzoni G, Scalise P, et al
    Duration of response after DEB-TACE compared to lipiodol-TACE in HCC-naive patients: a propensity score matching analysis.
    Eur Radiol. 2021;31:7512-7522.
    >> Share

  82. KONG C, Zhao Z, Chen W, Lv X, et al
    Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE.
    Eur Radiol. 2021;31:7500-7511.
    >> Share

  83. RONG D, Liu W, Kuang S, Xie S, et al
    Preoperative prediction of pathologic grade of HCC on gadobenate dimeglumine-enhanced dynamic MRI.
    Eur Radiol. 2021;31:7584-7593.
    >> Share

  84. GUPTA P, Bansal A, Das GC, Kumar-M P, et al
    Diagnostic accuracy of Liver Imaging Reporting and Data System locoregional treatment response criteria: a systematic review and meta-analysis.
    Eur Radiol. 2021;31:7725-7733.
    >> Share

    September 2021
  85. CARBONELL G, Kennedy P, Bane O, Kirmani A, et al
    Precision of MRI radiomics features in the liver and hepatocellular carcinoma.
    Eur Radiol. 2021 Sep 26. pii: 10.1007/s00330-021-08282.
    >> Share

  86. JANG JK, Kim SY, Yoo IW, Cho YB, et al
    Diagnostic performance of ultrasound attenuation imaging for assessing low-grade hepatic steatosis.
    Eur Radiol. 2021 Sep 21. pii: 10.1007/s00330-021-08269.
    >> Share

  87. YU Y, Fan Y, Wang X, Zhu M, et al
    Gd-EOB-DTPA-enhanced MRI radiomics to predict vessels encapsulating tumor clusters (VETC) and patient prognosis in hepatocellular carcinoma.
    Eur Radiol. 2021 Sep 4. pii: 10.1007/s00330-021-08250.
    >> Share

  88. FRONDA M, Doriguzzi Breatta A, Gatti M, Calandri M, et al
    Quantitative assessment of HCC wash-out on CT is a predictor of early complete response to TACE.
    Eur Radiol. 2021;31:6578-6588.
    >> Share

  89. KANG JH, Choi SH, Lee JS, Kim KW, et al
    Inter-reader reliability of CT Liver Imaging Reporting and Data System according to imaging analysis methodology: a systematic review and meta-analysis.
    Eur Radiol. 2021;31:6856-6867.
    >> Share

  90. LI W, Li L, Zhuang BW, Ruan SM, et al
    Inter-reader agreement of CEUS LI-RADS among radiologists with different levels of experience.
    Eur Radiol. 2021;31:6758-6767.
    >> Share

  91. WANG G, Xie X, Chen H, Zhong Z, et al
    Development of a pediatric liver CEUS criterion to classify benign and malignant liver lesions in pediatric patients: a pilot study.
    Eur Radiol. 2021;31:6747-6757.
    >> Share

  92. GUPTA P, Maralakunte M, Sagar S, Kumar-M P, et al
    Efficacy and safety of irreversible electroporation for malignant liver tumors: a systematic review and meta-analysis.
    Eur Radiol. 2021;31:6511-6521.
    >> Share

  93. CANNELLA R, Fraum TJ, Ludwig DR, Borhani AA, et al
    Targetoid appearance on T2-weighted imaging and signs of tumor vascular involvement: diagnostic value for differentiating HCC from other primary liver carcinomas.
    Eur Radiol. 2021;31:6868-6878.
    >> Share

  94. LAIMER G, Jaschke N, Schullian P, Putzer D, et al
    Volumetric assessment of the periablational safety margin after thermal ablation of colorectal liver metastases.
    Eur Radiol. 2021;31:6489-6499.
    >> Share

    August 2021
  95. OCAL O, Peynircioglu B, Loewe C, van Delden O, et al
    Correlation of liver enhancement in gadoxetic acid-enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial.
    Eur Radiol. 2021 Aug 31. pii: 10.1007/s00330-021-08218.
    >> Share

  96. CHEN J, Allen AM, Therneau TM, Chen J, et al
    Liver stiffness measurement by magnetic resonance elastography is not affected by hepatic steatosis.
    Eur Radiol. 2021 Aug 25. pii: 10.1007/s00330-021-08225.
    >> Share

  97. KIM GH, Kim PH, Kim JH, Kim PN, et al
    Thermal ablation in the treatment of intrahepatic cholangiocarcinoma: a systematic review and meta-analysis.
    Eur Radiol. 2021 Aug 4. pii: 10.1007/s00330-021-08216.
    >> Share

  98. NAGAYAMA Y, Kato Y, Inoue T, Nakaura T, et al
    Liver fibrosis assessment with multiphasic dual-energy CT: diagnostic performance of iodine uptake parameters.
    Eur Radiol. 2021;31:5779-5790.
    >> Share

  99. YOH T, Perrot A, Beaufrere A, Hobeika C, et al
    Liver surface nodularity: a novel predictor of post-hepatectomy liver failure in patients with colorectal liver metastases following chemotherapy.
    Eur Radiol. 2021;31:5830-5839.
    >> Share

  100. KOH DM, Ba-Ssalamah A, Brancatelli G, Fananapazir G, et al
    Consensus report from the 9(th) International Forum for Liver Magnetic Resonance Imaging: applications of gadoxetic acid-enhanced imaging.
    Eur Radiol. 2021;31:5615-5628.
    >> Share

  101. CHENG MQ, Hu HT, Huang H, Pan JM, et al
    Pathological considerations of CEUS LI-RADS: correlation with fibrosis stage and tumour histological grade.
    Eur Radiol. 2021;31:5680-5688.
    >> Share

  102. ALI A, Ahle M, Bjornsson B, Sandstrom P, et al
    Portal vein embolization with N-butyl cyanoacrylate glue is superior to other materials: a systematic review and meta-analysis.
    Eur Radiol. 2021;31:5464-5478.
    >> Share

  103. LEE DH, Lee ES, Bae JS, Lee JY, et al
    2D shear wave elastography is better than transient elastography in predicting post-hepatectomy complication after resection.
    Eur Radiol. 2021;31:5802-5811.
    >> Share

  104. HABIBZADEH F, Habibzadeh P, Shakibafard A, Saidi F, et al
    Predicting the outcome of asymptomatic univesicular liver hydatids: diagnostic accuracy of unenhanced CT.
    Eur Radiol. 2021;31:5812-5817.
    >> Share

  105. LIU LH, Zhou GF, Lv H, Wang ZC, et al
    Identifying response in colorectal liver metastases treated with bevacizumab: development of RECIST by combining contrast-enhanced and diffusion-weighted MRI.
    Eur Radiol. 2021;31:5640-5649.
    >> Share

    July 2021
  106. ZHOU C, Wang Y, Ma L, Qian X, et al
    Combined hepatocellular carcinoma-cholangiocarcinoma: MRI features correlated with tumor biomarkers and prognosis.
    Eur Radiol. 2021 Jul 19. pii: 10.1007/s00330-021-08188.
    >> Share

  107. NAJAFI A, de Baere T, Purenne E, Bayar A, et al
    Risk factors for local tumor progression after RFA of pulmonary metastases: a matched case-control study.
    Eur Radiol. 2021;31:5361-5369.
    >> Share

  108. HASENSTAB K, Cunha GM, Ichikawa S, Dehkordy SF, et al
    CNN color-coded difference maps accurately display longitudinal changes in liver MRI-PDFF.
    Eur Radiol. 2021;31:5041-5049.
    >> Share

  109. HUANG M, Shen S, Cai H, Peng Z, et al
    Regional liver function analysis with gadoxetic acid-enhanced MRI and virtual hepatectomy: prediction of postoperative short-term outcomes for HCC.
    Eur Radiol. 2021;31:4720-4730.
    >> Share

  110. MAO B, Ma J, Duan S, Xia Y, et al
    Preoperative classification of primary and metastatic liver cancer via machine learning-based ultrasound radiomics.
    Eur Radiol. 2021;31:4576-4586.
    >> Share

  111. PARK JH, Seo N, Chung YE, Kim SU, et al
    Noninvasive evaluation of liver fibrosis: comparison of the stretched exponential diffusion-weighted model to other diffusion-weighted MRI models and transient elastography.
    Eur Radiol. 2021;31:4813-4823.
    >> Share

  112. GUPTA P, Maralakunte M, Kumar-M P, Chandel K, et al
    Overall survival and local recurrence following RFA, MWA, and cryoablation of very early and early HCC: a systematic review and Bayesian network meta-analysis.
    Eur Radiol. 2021;31:5400-5408.
    >> Share

  113. YOUN SY, Kim DH, Choi SH, Kim B, et al
    Diagnostic performance of Liver Imaging Reporting and Data System treatment response algorithm: a systematic review and meta-analysis.
    Eur Radiol. 2021;31:4785-4793.
    >> Share

    June 2021
  114. YOON JH, Lee JM, Yu MH, Hur BY, et al
    Simultaneous evaluation of perfusion and morphology using GRASP MRI in hepatic fibrosis.
    Eur Radiol. 2021 Jun 12. pii: 10.1007/s00330-021-08087.
    >> Share

  115. VICENTIN I, Mosconi C, Garanzini E, Sposito C, et al
    Inter-center agreement of mRECIST in transplanted patients for hepatocellular carcinoma.
    Eur Radiol. 2021 Jun 12. pii: 10.1007/s00330-021-08088.
    >> Share

  116. OBMANN VC, Berzigotti A, Catucci D, Ebner L, et al
    T1 mapping of the liver and the spleen in patients with liver fibrosis-does normalization to the blood pool increase the predictive value?
    Eur Radiol. 2021;31:4308-4318.
    >> Share

  117. JIANG H, Song B, Qin Y, Chen J, et al
    Diagnosis of LI-RADS M lesions on gadoxetate-enhanced MRI: identifying cholangiocarcinoma-containing tumor with serum markers and imaging features.
    Eur Radiol. 2021;31:3638-3648.
    >> Share

  118. MIN JH, Kim SH, Hwang JA, Hyun SH, et al
    Prognostic value of LI-RADS category on gadoxetic acid-enhanced MRI and 18F-FDG PET-CT in patients with primary liver carcinomas.
    Eur Radiol. 2021;31:3649-3660.
    >> Share

  119. HECTORS SJ, Kennedy P, Huang KH, Stocker D, et al
    Fully automated prediction of liver fibrosis using deep learning analysis of gadoxetic acid-enhanced MRI.
    Eur Radiol. 2021;31:3805-3814.
    >> Share

    May 2021
  120. STOCKER D, Hectors S, Bane O, Vietti-Violi N, et al
    Dynamic contrast-enhanced MRI perfusion quantification in hepatocellular carcinoma: comparison of gadoxetate disodium and gadobenate dimeglumine.
    Eur Radiol. 2021 May 27. pii: 10.1007/s00330-021-08068.
    >> Share

  121. CHOI SH, Jeon SK, Lee SS, Lee JM, et al
    Radio-pathologic correlation of biphenotypic primary liver cancer (combined hepatocellular cholangiocarcinoma): changes in the 2019 WHO classification and impact on LI-RADS classification at liver MRI.
    Eur Radiol. 2021 May 26. pii: 10.1007/s00330-021-07984.
    >> Share

  122. KIM PH, Hwang J, Yoon HM, Shin HJ, et al
    Outcome of staging chest CT and identification of factors associated with lung metastasis in children with hepatoblastoma.
    Eur Radiol. 2021 May 25. pii: 10.1007/s00330-021-08047.
    >> Share

  123. NOWAK S, Mesropyan N, Faron A, Block W, et al
    Detection of liver cirrhosis in standard T2-weighted MRI using deep transfer learning.
    Eur Radiol. 2021 May 11. pii: 10.1007/s00330-021-07858.
    >> Share

  124. BAE H, Lee H, Kim S, Han K, et al
    Radiomics analysis of contrast-enhanced CT for classification of hepatic focal lesions in colorectal cancer patients: its limitations compared to radiologists.
    Eur Radiol. 2021 May 10. pii: 10.1007/s00330-021-07877.
    >> Share

  125. REIMER RP, Grosse Hokamp N, Fehrmann Efferoth A, Krauskopf A, et al
    Virtual monoenergetic images from spectral detector computed tomography facilitate washout assessment in arterially hyper-enhancing liver lesions.
    Eur Radiol. 2021;31:3468-3477.
    >> Share

  126. SCHULLIAN P, Johnston E, Laimer G, Putzer D, et al
    Frequency and risk factors for major complications after stereotactic radiofrequency ablation of liver tumors in 1235 ablation sessions: a 15-year experience.
    Eur Radiol. 2021;31:3042-3052.
    >> Share

  127. SAVIC LJ, Chapiro J, Funai E, Bousabarah K, et al
    Prospective study of Lipiodol distribution as an imaging marker for doxorubicin pharmacokinetics during conventional transarterial chemoembolization of liver malignancies.
    Eur Radiol. 2021;31:3002-3014.
    >> Share

    April 2021
  128. LIN CC, Lui KW, Chen WT, Hsieh YC, et al
    Switching monopolar radiofrequency ablation improves long-term outcomes of medium-sized hepatocellular carcinoma.
    Eur Radiol. 2021 Apr 25. pii: 10.1007/s00330-021-07729.
    >> Share

  129. PARK HJ, Park B, Park SY, Choi SH, et al
    Preoperative prediction of postsurgical outcomes in mass-forming intrahepatic cholangiocarcinoma based on clinical, radiologic, and radiomics features.
    Eur Radiol. 2021 Apr 23. pii: 10.1007/s00330-021-07926.
    >> Share

  130. LEE HJ, Hong SB, Lee NK, Kim S, et al
    Validation of functional liver imaging scores (FLIS) derived from gadoxetic acid-enhanced MRI in patients with chronic liver disease and liver cirrhosis: the relationship between Child-Pugh score and FLIS.
    Eur Radiol. 2021 Apr 21. pii: 10.1007/s00330-021-07955.
    >> Share

  131. RYU H, Shin SY, Lee JY, Lee KM, et al
    Joint segmentation and classification of hepatic lesions in ultrasound images using deep learning.
    Eur Radiol. 2021 Apr 21. pii: 10.1007/s00330-021-07850.
    >> Share

  132. TANG M, Zhou Q, Huang M, Sun K, et al
    Nomogram development and validation to predict hepatocellular carcinoma tumor behavior by preoperative gadoxetic acid-enhanced MRI.
    Eur Radiol. 2021 Apr 20. pii: 10.1007/s00330-021-07941.
    >> Share

  133. CUNHA GM, Hasenstab KA, Delgado T, Ichikawa S, et al
    Multi-arterial phase MRI depicts inconsistent arterial phase hyperenhancement (APHE) subtypes in liver observations of patients at risk for hepatocellular carcinoma.
    Eur Radiol. 2021 Apr 19. pii: 10.1007/s00330-021-07924.
    >> Share

  134. CHEN J, Xia C, Duan T, Cao L, et al
    Macrotrabecular-massive hepatocellular carcinoma: imaging identification and prediction based on gadoxetic acid-enhanced magnetic resonance imaging.
    Eur Radiol. 2021 Apr 15. pii: 10.1007/s00330-021-07898.
    >> Share

  135. HWANG JA, Min JH, Kang TW, Jeong WK, et al
    Assessment of factors affecting washout appearance of hepatocellular carcinoma on CT.
    Eur Radiol. 2021 Apr 15. pii: 10.1007/s00330-021-07897.
    >> Share

  136. STROBEL D, Jung EM, Ziesch M, Praktiknjo M, et al
    Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS(R)/ESCULAP) in hepatic nodules in cirrhotic patients-a prospective multicenter study.
    Eur Radiol. 2021 Apr 15. pii: 10.1007/s00330-021-07872.
    >> Share

  137. GHORRA C, Pommier R, Piveteau A, Rubbia-Brandt L, et al
    The diagnostic performance of a simulated "short" gadoxetic acid-enhanced MRI protocol is similar to that of a conventional protocol for the detection of colorectal liver metastases.
    Eur Radiol. 2021;31:2451-2460.
    >> Share

    Interventional radiology for liver diseases.
    Eur Radiol. 2021;31:2227-2230.
    >> Share

  139. KIM DH, Choi SH, Park SH, Kim KW, et al
    The Liver Imaging Reporting and Data System tumor-in-vein category: a systematic review and meta-analysis.
    Eur Radiol. 2021;31:2497-2506.
    >> Share

  140. VOGL TJ, Marko C, Langenbach MC, Naguib NNN, et al
    Transarterial chemoembolization of colorectal cancer liver metastasis: improved tumor response by DSM-TACE versus conventional TACE, a prospective, randomized, single-center trial.
    Eur Radiol. 2021;31:2242-2251.
    >> Share

    March 2021
  141. YANG W, Kim JE, Choi HC, Park MJ, et al
    T2 mapping in gadoxetic acid-enhanced MRI: utility for predicting decompensation and death in cirrhosis.
    Eur Radiol. 2021 Mar 29. pii: 10.1007/s00330-021-07805.
    >> Share

  142. ZHANG Y, Tang W, Xie S, Chen J, et al
    The role of lesion hypointensity on gadobenate dimeglumine-enhanced hepatobiliary phase MRI as an additional major imaging feature for HCC classification using LI-RADS v2018 criteria.
    Eur Radiol. 2021 Mar 29. pii: 10.1007/s00330-021-07807.
    >> Share

  143. TSAI YC, Shih JH, Hwang HE, Chiu NC, et al
    Early prediction of 1-year tumor response of hepatocellular carcinoma with lipiodol deposition pattern through post-embolization cone-beam computed tomography during conventional transarterial chemoembolization.
    Eur Radiol. 2021 Mar 25. pii: 10.1007/s00330-021-07843.
    >> Share

  144. KIM DW, Lee G, Kim SY, Ahn G, et al
    Deep learning-based algorithm to detect primary hepatic malignancy in multiphase CT of patients at high risk for HCC.
    Eur Radiol. 2021 Mar 18. pii: 10.1007/s00330-021-07803.
    >> Share

  145. CHA DI, Lee MW, Jeong WK, Ahn SH, et al
    Rim-arterial enhancing primary hepatic tumors with other targetoid appearance show early recurrence after radiofrequency ablation.
    Eur Radiol. 2021 Mar 13. pii: 10.1007/s00330-021-07769.
    >> Share

  146. RONOT M, Ferraioli G, Muller HP, Friedrich-Rust M, et al
    Comparison of liver stiffness measurements by a 2D-shear wave technique and transient elastography: results from a European prospective multi-centre study.
    Eur Radiol. 2021;31:1578-1587.
    >> Share

  147. SARWAR A, Kudla A, Weinstein JL, Ali A, et al
    Yttrium-90 radioembolization using MIRD dosimetry with resin microspheres.
    Eur Radiol. 2021;31:1316-1324.
    >> Share

  148. XU X, Zhu H, Li R, Lin H, et al
    Whole-liver histogram and texture analysis on T1 maps improves the risk stratification of advanced fibrosis in NAFLD.
    Eur Radiol. 2021;31:1748-1759.
    >> Share

  149. SHAGHAGHI M, Aliyari Ghasabeh M, Ameli S, Ghadimi M, et al
    Post-TACE changes in ADC histogram predict overall and transplant-free survival in patients with well-defined HCC: a retrospective cohort with up to 10 years follow-up.
    Eur Radiol. 2021;31:1378-1390.
    >> Share

  150. LEFEBVRE T, Hebert M, Bilodeau L, Sebastiani G, et al
    Intravoxel incoherent motion diffusion-weighted MRI for the characterization of inflammation in chronic liver disease.
    Eur Radiol. 2021;31:1347-1358.
    >> Share

  151. COLAGRANDE S, Calistri L, Campani C, Dragoni G, et al
    CT volume of enhancement of disease (VED) can predict the early response to treatment and overall survival in patients with advanced HCC treated with sorafenib.
    Eur Radiol. 2021;31:1608-1619.
    >> Share

    February 2021
  152. ZHOU Y, Zhou G, Zhang J, Xu C, et al
    Radiomics signature on dynamic contrast-enhanced MR images: a potential imaging biomarker for prediction of microvascular invasion in mass-forming intrahepatic cholangiocarcinoma.
    Eur Radiol. 2021 Feb 26. pii: 10.1007/s00330-021-07793.
    >> Share

  153. GOU Q, Wu L, Cui W, Mo Z, et al
    Stent placement combined with intraluminal radiofrequency ablation and hepatic arterial infusion chemotherapy for advanced biliary tract cancers with biliary obstruction: a multicentre, retrospective, controlled study.
    Eur Radiol. 2021 Feb 13. pii: 10.1007/s00330-021-07716.
    >> Share

  154. LIU C, Sun Y, Yang Y, Feng Y, et al
    Gadobenate dimeglumine-enhanced biliary imaging from the hepatobiliary phase can predict progression in patients with liver cirrhosis.
    Eur Radiol. 2021 Feb 3. pii: 10.1007/s00330-021-07702.
    >> Share

  155. LEE S, Kim SS, Bae H, Shin J, et al
    Application of Liver Imaging Reporting and Data System version 2018 ancillary features to upgrade from LR-4 to LR-5 on gadoxetic acid-enhanced MRI.
    Eur Radiol. 2021;31:855-863.
    >> Share

  156. DING J, Long L, Zhang X, Chen C, et al
    Contrast-enhanced ultrasound LI-RADS 2017: comparison with CT/MRI LI-RADS.
    Eur Radiol. 2021;31:847-854.
    >> Share

    January 2021
  157. YANG J, Huang JY, Chen X, Ling WW, et al
    Combined hepatocellular-cholangiocarcinoma: can we use contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) to predict the patient's survival?
    Eur Radiol. 2021 Jan 25. pii: 10.1007/s00330-020-07656.
    >> Share

  158. KENNEDY P, Lewis S, Bane O, Hectors SJ, et al
    Early effect of (90)Y radioembolisation on hepatocellular carcinoma and liver parenchyma stiffness measured with MR elastography: initial experience.
    Eur Radiol. 2021 Jan 21. pii: 10.1007/s00330-020-07636.
    >> Share

  159. BEAUMONT H, Iannessi A, Bertrand AS, Cucchi JM, et al
    Harmonization of radiomic feature distributions: impact on classification of hepatic tissue in CT imaging.
    Eur Radiol. 2021 Jan 18. pii: 10.1007/s00330-020-07641.
    >> Share

  160. CHONG HH, Yang L, Sheng RF, Yu YL, et al
    Multi-scale and multi-parametric radiomics of gadoxetate disodium-enhanced MRI predicts microvascular invasion and outcome in patients with solitary hepatocellular carcinoma
    Eur Radiol. 2021 Jan 14. pii: 10.1007/s00330-020-07601.
    >> Share

  161. HECTORS SJ, Bane O, Kennedy P, Cuevas J, et al
    Noninvasive diagnosis of portal hypertension using gadoxetate DCE-MRI of the liver and spleen.
    Eur Radiol. 2021 Jan 7. pii: 10.1007/s00330-020-07495.
    >> Share

  162. DARNELL A, Rimola J, Belmonte E, Ripoll E, et al
    Evaluation of LI-RADS 3 category by magnetic resonance in US-detected nodules
    Eur Radiol. 2021 Jan 6. pii: 10.1007/s00330-020-07457.
    >> Share

  163. HWANG SH, Park MS, Park S, Lim JS, et al
    Comparison of the current guidelines for diagnosing hepatocellular carcinoma using gadoxetic acid-enhanced magnetic resonance imaging.
    Eur Radiol. 2021 Jan 6. pii: 10.1007/s00330-020-07468.
    >> Share

  164. ZHOU GP, Jiang YZ, Sun LY, Zhu ZJ, et al
    Early transjugular intrahepatic portosystemic shunt for acute variceal bleeding: a systematic review and meta-analysis.
    Eur Radiol. 2021 Jan 6. pii: 10.1007/s00330-020-07525.
    >> Share

  165. OESTMANN PM, Wang CJ, Savic LJ, Hamm CA, et al
    Deep learning-assisted differentiation of pathologically proven atypical and typical hepatocellular carcinoma (HCC) versus non-HCC on contrast-enhanced MRI of the liver.
    Eur Radiol. 2021 Jan 6. pii: 10.1007/s00330-020-07559.
    >> Share

  166. ZHUANG BW, Li W, Wang W, Li B, et al
    Treatment effect of radiofrequency ablation versus liver transplantation and surgical resection for hepatocellular carcinoma within Milan criteria: a population-based study.
    Eur Radiol. 2021 Jan 6. pii: 10.1007/s00330-020-07551.
    >> Share

  167. AN C, Li WZ, Huang ZM, Yu XL, et al
    Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
    Eur Radiol. 2021 Jan 5. pii: 10.1007/s00330-020-07571.
    >> Share

  168. PARK SH, Shim YS, Kim B, Kim SY, et al
    Retrospective analysis of current guidelines for hepatocellular carcinoma diagnosis on gadoxetic acid-enhanced MRI in at-risk patients.
    Eur Radiol. 2021 Jan 3. pii: 10.1007/s00330-020-07577.
    >> Share

  169. ALSHEHRI E, Lam CZ, Kamath BM, Chavhan GB, et al
    Abdominal lymphatic system visibility, morphology, and abnormalities in children as seen on routine MCRP and its association with immune-mediated diseases.
    Eur Radiol. 2021;31:292-301.
    >> Share

  170. GU K, Jeon TY, Yoo SY, Kim JH, et al
    Gd-EOB-DTPA MRI for focal nodular hyperplasia-like lesions in pediatric cancer survivors.
    Eur Radiol. 2021;31:283-291.
    >> Share

  171. SEO N, Jeong HK, Choi JY, Park MS, et al
    Liver MRI with amide proton transfer imaging: feasibility and accuracy for the characterization of focal liver lesions.
    Eur Radiol. 2021;31:222-231.
    >> Share

  172. STEINKOHL F, Barbieri F, Senoner T, Strobl S, et al
    Coronary atherosclerosis profile in patients with end-stage liver disease prior to liver transplantation due to alcoholic fatty liver: a coronary CTA study.
    Eur Radiol. 2021;31:494-503.
    >> Share

  173. TSAUO J, Noh SY, Shin JH, Gwon DI, et al
    Retrograde transvenous obliteration for the prevention of variceal rebleeding in patients with portal vein thrombosis: a multicenter study.
    Eur Radiol. 2021;31:559-566.
    >> Share

    December 2020
  174. VOSSHENRICH J, Zech CJ, Heye T, Boldanova T, et al
    Response prediction of hepatocellular carcinoma undergoing transcatheter arterial chemoembolization: unlocking the potential of CT texture analysis through nested decision tree models.
    Eur Radiol. 2020 Dec 3. pii: 10.1007/s00330-020-07511.
    >> Share

  175. VELTRI A, Basile D, Calandri M, Bertaggia C, et al
    Oligometastatic adrenocortical carcinoma: the role of image-guided thermal ablation.
    Eur Radiol. 2020;30:6958-6964.
    >> Share

    November 2020
  176. PACHEV A, Raynaud L, Paulatto L, Burgio MD, et al
    Correction to: Predictive factors of severe abdominal pain during and after transarterial chemoembolization for hepatocellular carcinoma.
    Eur Radiol. 2020 Nov 27. pii: 10.1007/s00330-020-07506.
    >> Share

  177. ZHANG J, Wu Z, Zhao J, Liu S, et al
    Intrahepatic cholangiocarcinoma: MRI texture signature as predictive biomarkers of immunophenotyping and survival.
    Eur Radiol. 2020 Nov 27. pii: 10.1007/s00330-020-07524.
    >> Share

  178. CHU HH, Chun SY, Kim JH, Kim PH, et al
    A prediction model for overall survival after transarterial chemoembolization for hepatocellular carcinoma invading the hepatic vein or inferior vena cava.
    Eur Radiol. 2020 Nov 26. pii: 10.1007/s00330-020-07536.
    >> Share

  179. SEO N, Kim MS, Park MS, Choi JY, et al
    Correction to: Evaluation of treatment response in hepatocellular carcinoma in the explanted liver with Liver Imaging Reporting and Data System version 2017.
    Eur Radiol. 2020 Nov 23. pii: 10.1007/s00330-020-07444.
    >> Share

  180. BAE JS, Kim JH, Lee DH, Kim JH, et al
    Hepatobiliary phase of gadoxetic acid-enhanced MRI in patients with HCC: prognostic features before resection, ablation, or TACE.
    Eur Radiol. 2020 Nov 19. pii: 10.1007/s00330-020-07499.
    >> Share

  181. HU X, Huang X, Hou J, Ding L, et al
    Correction to: Diagnostic accuracy of spleen stiffness to evaluate portal hypertension and esophageal varices in chronic liver disease: a systematic review and meta-analysis.
    Eur Radiol. 2020 Nov 18. pii: 10.1007/s00330-020-07446.
    >> Share

  182. YANG Y, Chen Y, Ye F, Cao X, et al
    Late recurrence of hepatocellular carcinoma after radiofrequency ablation: a multicenter study of risk factors, patterns, and survival.
    Eur Radiol. 2020 Nov 11. pii: 10.1007/s00330-020-07460.
    >> Share

  183. MIN JH, Kang TW, Kim YY, Cha DI, et al
    Vanishing washout of hepatocellular carcinoma according to the presence of hepatic steatosis: diagnostic performance of CT and MRI.
    Eur Radiol. 2020 Nov 7. pii: 10.1007/s00330-020-07438.
    >> Share

  184. KIM SS, Lee S, Kim MJ
    Prognostic factors of gadoxetic acid-enhanced MRI for postsurgical outcomes in multicentric hepatocellular carcinoma.
    Eur Radiol. 2020 Nov 4. pii: 10.1007/s00330-020-07419.
    >> Share

  185. REIZINE E, Ronot M, Ghosn M, Calderaro J, et al
    Hepatospecific MR contrast agent uptake on hepatobiliary phase can be used as a biomarker of marked beta-catenin activation in hepatocellular adenoma.
    Eur Radiol. 2020 Nov 4. pii: 10.1007/s00330-020-07434.
    >> Share

  186. LI C, Ye J, Prince M, Peng Y, et al
    Comparing mono-exponential, bi-exponential, and stretched-exponential diffusion-weighted MR imaging for stratifying non-alcoholic fatty liver disease in a rabbit model.
    Eur Radiol. 2020;30:6022-6032.
    >> Share

  187. KROMREY ML, Tamada D, Johno H, Funayama S, et al
    Reduction of respiratory motion artifacts in gadoxetate-enhanced MR with a deep learning-based filter using convolutional neural network.
    Eur Radiol. 2020;30:5923-5932.
    >> Share

  188. PLAIKNER M, Kremser C, Zoller H, Jaschke W, et al
    Evaluation of liver iron overload with R2* relaxometry with versus without fat suppression: both are clinically accurate but there are differences.
    Eur Radiol. 2020;30:5826-5833.
    >> Share

  189. QIAO W, Yu Y, Huang Y, Gao W, et al
    Impact of focused ultrasound on the ethanol ablation of VX2 liver tumours in rabbits.
    Eur Radiol. 2020;30:5862-5870.
    >> Share

    October 2020
  190. LADA NE, Gupta A, Anderson SW, Dinh DC, et al
    Liver trauma: hepatic vascular injury on computed tomography as a predictor of patient outcome.
    Eur Radiol. 2020 Oct 30. pii: 10.1007/s00330-020-07373.
    >> Share

  191. DOEMEL LA, Chapiro J, Laage Gaupp F, Savic LJ, et al
    Reliable prediction of survival in advanced-stage hepatocellular carcinoma treated with sorafenib: comparing 1D and 3D quantitative tumor response criteria on MRI.
    Eur Radiol. 2020 Oct 30. pii: 10.1007/s00330-020-07381.
    >> Share

  192. CHUANG YH, Hsieh CS, Lai MW, Chen CC, et al
    Detection of pediatric hepatic steatosis through ultrasound backscattering analysis.
    Eur Radiol. 2020 Oct 30. pii: 10.1007/s00330-020-07391.
    >> Share

  193. LEE CM, Lee SS, Choi WM, Kim KM, et al
    An index based on deep learning-measured spleen volume on CT for the assessment of high-risk varix in B-viral compensated cirrhosis.
    Eur Radiol. 2020 Oct 30. pii: 10.1007/s00330-020-07430.
    >> Share

  194. PACHEV A, Rauyaud L, Paulatto L, Dioguardi Burgio M, et al
    Predictive factors of severe abdominal pain during and after transarterial chemoembolization for hepatocellular carcinoma.
    Eur Radiol. 2020 Oct 29. pii: 10.1007/s00330-020-07404.
    >> Share

  195. HWANG SH, Hong SB, Park S, Han K, et al
    Subcentimeter hepatocellular carcinoma in treatment-naive patients: noninvasive diagnostic criteria and tumor staging on gadoxetic acid-enhanced MRI.
    Eur Radiol. 2020 Oct 12. pii: 10.1007/s00330-020-07329.
    >> Share

  196. CHOUHAN MD, Taylor SA, Bainbridge A, Walker-Samuel S, et al
    Haemodynamic changes in cirrhosis following terlipressin and induction of sepsis-a preclinical study using caval subtraction phase-contrast and cardiac MRI.
    Eur Radiol. 2020 Oct 12. pii: 10.1007/s00330-020-07259.
    >> Share

  197. LUO N, Li W, Xie J, Fu D, et al
    Preoperative normalized iodine concentration derived from spectral CT is correlated with early recurrence of hepatocellular carcinoma after curative resection.
    Eur Radiol. 2020 Oct 9. pii: 10.1007/s00330-020-07330.
    >> Share

  198. CHU H, Liu Z, Liang W, Zhou Q, et al
    Radiomics using CT images for preoperative prediction of futile resection in intrahepatic cholangiocarcinoma.
    Eur Radiol. 2020 Oct 8. pii: 10.1007/s00330-020-07250.
    >> Share

  199. KIM B, Kim SS, Cho SW, Cheong JY, et al
    Liver stiffness in magnetic resonance elastography is prognostic for sorafenib-treated advanced hepatocellular carcinoma.
    Eur Radiol. 2020 Oct 8. pii: 10.1007/s00330-020-07357.
    >> Share

  200. BAE JS, Lee DH, Yoo J, Yi NJ, et al
    Association between spleen volume and the post-hepatectomy liver failure and overall survival of patients with hepatocellular carcinoma after resection.
    Eur Radiol. 2020 Oct 7. pii: 10.1007/s00330-020-07313.
    >> Share

  201. LI J, Sehrawat TS, Chen J, Hilscher MB, et al
    Quantitative assessment of portal hypertension with bi-parametric dual-frequency hepatic MR elastography in mouse models.
    Eur Radiol. 2020 Oct 7. pii: 10.1007/s00330-020-07341.
    >> Share

  202. WEI H, Jiang H, Zheng T, Zhang Z, et al
    LI-RADS category 5 hepatocellular carcinoma: preoperative gadoxetic acid-enhanced MRI for early recurrence risk stratification after curative resection.
    Eur Radiol. 2020 Oct 1. pii: 10.1007/s00330-020-07303.
    >> Share

  203. ZHANG L, Yu X, Wei W, Pan X, et al
    Prediction of HCC microvascular invasion with gadobenate-enhanced MRI: correlation with pathology.
    Eur Radiol. 2020;30:5327-5336.
    >> Share

    September 2020
  204. BONATTI M, Valletta R, Avesani G, Lombardo F, et al
    Liver enhancement during hepatobiliary phase after Gd-BOPTA administration: correlation with liver and renal function.
    Eur Radiol. 2020 Sep 30. pii: 10.1007/s00330-020-07279.
    >> Share

  205. HU X, Huang X, Hou J, Ding L, et al
    Diagnostic accuracy of spleen stiffness to evaluate portal hypertension and esophageal varices in chronic liver disease: a systematic review and meta-analysis.
    Eur Radiol. 2020 Sep 24. pii: 10.1007/s00330-020-07223.
    >> Share

  206. RUNGE JH, van Giessen J, Draijer LG, Deurloo EE, et al
    Accuracy of controlled attenuation parameter compared with ultrasound for detecting hepatic steatosis in children with severe obesity.
    Eur Radiol. 2020 Sep 10. pii: 10.1007/s00330-020-07245.
    >> Share

  207. ALIYARI GHASABEH M, Shaghaghi M, Pandey A, Ameli S, et al
    Integrating baseline MR imaging biomarkers into BCLC and CLIP improves overall survival prediction of patients with hepatocellular carcinoma (HCC).
    Eur Radiol. 2020 Sep 10. pii: 10.1007/s00330-020-07251.
    >> Share

  208. KIM SS, Lee S, Bae H, Chung YE, et al
    Extended application of subtraction arterial phase imaging in LI-RADS version 2018: a strategy to improve the diagnostic performance for hepatocellular carcinoma on gadoxetate disodium-enhanced MRI.
    Eur Radiol. 2020 Sep 4. pii: 10.1007/s00330-020-07229.
    >> Share

  209. BHAYANA R, Baliyan V, Kordbacheh H, Kambadakone A, et al
    Hepatobiliary phase enhancement of liver metastases on gadoxetic acid MRI: assessment of frequency and patterns.
    Eur Radiol. 2020 Sep 4. pii: 10.1007/s00330-020-07228.
    >> Share

  210. LEE JH, Yoon CJ, Choi WS
    Transhepatic stent placement for portal vein obstruction after hepatobiliary and pancreatic surgery: long-term efficacy and risk factor for stent failure.
    Eur Radiol. 2020 Sep 3. pii: 10.1007/s00330-020-07139.
    >> Share

  211. KALARAKIS G, Perisinakis K, Akoumianakis E, Karageorgiou I, et al
    CT liver perfusion in patients with hepatocellular carcinoma: can we modify acquisition protocol to reduce patient exposure?
    Eur Radiol. 2020 Sep 2. pii: 10.1007/s00330-020-07206.
    >> Share

  212. NOUGARET S, Monsonis B, Molinari N, Riviere B, et al
    Quantification of liver fat content in liver and primary liver lesions using triple-echo-gradient-echo MRI.
    Eur Radiol. 2020;30:4752-4761.
    >> Share

  213. IDILMAN IS, Venkatesh SH, Eaton JE, Bolan CW, et al
    Magnetic resonance imaging features in 283 patients with primary biliary cholangitis.
    Eur Radiol. 2020;30:5139-5148.
    >> Share

    August 2020
  214. KANG HJ, Lee JM, Jeon SK, Jang S, et al
    Intra-individual comparison of dual portal venous phases for non-invasive diagnosis of hepatocellular carcinoma at gadoxetic acid-enhanced liver MRI.
    Eur Radiol. 2020 Aug 26. pii: 10.1007/s00330-020-07162.
    >> Share

  215. NODA Y, Tochigi T, Baliyan V, Kordbacheh H, et al
    Hepatobiliary contrast uptake patterns on gadoxetic acid-enhanced MRI in liver metastases from pancreatic ductal adenocarcinoma: can it predict prognosis?
    Eur Radiol. 2020 Aug 12. pii: 10.1007/s00330-020-07115.
    >> Share

  216. CATANIA R, Furlan A, Smith AD, Behari J, et al
    Diagnostic value of MRI-derived liver surface nodularity score for the non-invasive quantification of hepatic fibrosis in non-alcoholic fatty liver disease.
    Eur Radiol. 2020 Aug 5. pii: 10.1007/s00330-020-07114.
    >> Share

  217. LIU X, Khalvati F, Namdar K, Fischer S, et al
    Can machine learning radiomics provide pre-operative differentiation of combined hepatocellular cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma to inform optimal treatment planning?
    Eur Radiol. 2020 Aug 4. pii: 10.1007/s00330-020-07119.
    >> Share

  218. MESROPYAN N, Isaak A, Faron A, Praktiknjo M, et al
    Magnetic resonance parametric mapping of the spleen for non-invasive assessment of portal hypertension.
    Eur Radiol. 2020 Aug 4. pii: 10.1007/s00330-020-07080.
    >> Share

  219. VIETTI VIOLI N, Taouli B
    Abbreviated MRI for HCC surveillance: is it ready for clinical use?
    Eur Radiol. 2020;30:4147-4149.
    >> Share

  220. SCHAWKAT K, Ciritsis A, von Ulmenstein S, Honcharova-Biletska H, et al
    Diagnostic accuracy of texture analysis and machine learning for quantification of liver fibrosis in MRI: correlation with MR elastography and histopathology.
    Eur Radiol. 2020;30:4675-4685.
    >> Share

  221. CHO HJ, Kim B, Kim HJ, Huh J, et al
    Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment.
    Eur Radiol. 2020;30:4182-4192.
    >> Share

    July 2020
  222. ZHANG Y, Miao H, Xie W, Jiang S, et al
    The PPRD score stratifies patients with hepatocellular carcinoma and portal vein tumor thrombus treated with sorafenib plus transarterial chemoembolization.
    Eur Radiol. 2020 Jul 29. pii: 10.1007/s00330-020-07078.
    >> Share

  223. MAO B, Zhang L, Ning P, Ding F, et al
    Preoperative prediction for pathological grade of hepatocellular carcinoma via machine learning-based radiomics.
    Eur Radiol. 2020 Jul 22. pii: 10.1007/s00330-020-07056.
    >> Share

  224. AMELI S, Shaghaghi M, Ghasabeh MA, Pandey P, et al
    Does the change in volumetric functional MR metrics post-TACE predict histopathologic grading of hepatocellular carcinoma?
    Eur Radiol. 2020 Jul 15. pii: 10.1007/s00330-020-07052.
    >> Share

  225. CHA DI, Choi GS, Kim YK, Kim JM, et al
    Extracellular contrast-enhanced MRI with diffusion-weighted imaging for HCC diagnosis: prospective comparison with gadoxetic acid using LI-RADS.
    Eur Radiol. 2020;30:3723-3734.
    >> Share

  226. VOGL TJ, Martin SS, Johnson AA, Haas Y, et al
    Evaluation of MR elastography as a response parameter for transarterial chemoembolization of colorectal liver metastases.
    Eur Radiol. 2020;30:3900-3907.
    >> Share

    June 2020
  227. HAYOZ R, Vietti-Violi N, Duran R, Knebel JF, et al
    The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine tumor.
    Eur Radiol. 2020 Jun 29. pii: 10.1007/s00330-020-06930.
    >> Share

  228. KERAMIDA G, Gregg S, Peters AM
    Stimulation of the hepatic arterial buffer response using exogenous adenosine: hepatic rest/stress perfusion imaging.
    Eur Radiol. 2020 Jun 27. pii: 10.1007/s00330-020-06984.
    >> Share

  229. VIETTI VIOLI N, Lewis S, Liao J, Hulkower M, et al
    Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening.
    Eur Radiol. 2020 Jun 25. pii: 10.1007/s00330-020-07014.
    >> Share

  230. FENG Y, Wu H, Huang DQ, Xu C, et al
    Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (
    Eur Radiol. 2020 Jun 11. pii: 10.1007/s00330-020-06990.
    >> Share

  231. ICHIKAWA S, Isoda H, Shimizu T, Tamada D, et al
    Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
    Eur Radiol. 2020 Jun 4. pii: 10.1007/s00330-020-06972.
    >> Share

  232. SON JH, Lee SS, Lee Y, Kang BK, et al
    Assessment of liver fibrosis severity using computed tomography-based liver and spleen volumetric indices in patients with chronic liver disease.
    Eur Radiol. 2020;30:3486-3496.
    >> Share

    May 2020
  233. DORI Y, Smith CL, DeWitt AG, Srinivasan A, et al
    Intramesenteric dynamic contrast pediatric MR lymphangiography: initial experience and comparison with intranodal and intrahepatic MR lymphangiography.
    Eur Radiol. 2020 May 27. pii: 10.1007/s00330-020-06949.
    >> Share

  234. SCHOBERT IT, Savic LJ, Chapiro J, Bousabarah K, et al
    Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE.
    Eur Radiol. 2020 May 19. pii: 10.1007/s00330-020-06931.
    >> Share

  235. KIM PH, Gwon DI, Kim JW, Chu HH, et al
    The safety and efficacy of balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma refractory to conventional transcatheter arterial chemoembolization.
    Eur Radiol. 2020 May 15. pii: 10.1007/s00330-020-06911.
    >> Share

  236. MULE S, Chalaye J, Legou F, Tenenhaus A, et al
    Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
    Eur Radiol. 2020 May 13. pii: 10.1007/s00330-020-06923.
    >> Share

  237. WANG X, Wang W, Ma X, Lu X, et al
    Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance?
    Eur Radiol. 2020 May 8. pii: 10.1007/s00330-020-06861.
    >> Share

  238. LYU L, Liu XL, Rui MP, Yang LC, et al
    Liver extracellular volume fraction values obtained with magnetic resonance imaging can quantitatively stage liver fibrosis: a validation study in monkeys with nonalcoholic steatohepatitis.
    Eur Radiol. 2020 May 6. pii: 10.1007/s00330-020-06902.
    >> Share

  239. CHEN J, Zhu J, Zhang C, Song Y, et al
    Contrast-enhanced ultrasound for the characterization of portal vein thrombosis vs tumor-in-vein in HCC patients: a systematic review and meta-analysis.
    Eur Radiol. 2020;30:2871-2880.
    >> Share

  240. STOCKER D, Becker AS, Barth BK, Skawran S, et al
    Does quantitative assessment of arterial phase hyperenhancement and washout improve LI-RADS v2018-based classification of liver lesions?
    Eur Radiol. 2020;30:2922-2933.
    >> Share

  241. KIM SW, Joo I, Kim HC, Ahn SJ, et al
    LI-RADS treatment response categorization on gadoxetic acid-enhanced MRI: diagnostic performance compared to mRECIST and added value of ancillary features.
    Eur Radiol. 2020;30:2861-2870.
    >> Share

    April 2020
  242. GREGORY J, Crequit P, Vilgrain V, Ronot M, et al
    Results of trials assessing transarterial chemoembolization for treating hepatocellular carcinoma are critically underreported.
    Eur Radiol. 2020 Apr 30. pii: 10.1007/s00330-020-06900.
    >> Share

  243. BAK S, Kim JE, Bae K, Cho JM, et al
    Quantification of liver extracellular volume using dual-energy CT: utility for prediction of liver-related events in cirrhosis.
    Eur Radiol. 2020 Apr 26. pii: 10.1007/s00330-020-06876.
    >> Share

  244. JEON SK, Lee JM, Joo I, Yoo J, et al
    Comparison of guidelines for diagnosis of hepatocellular carcinoma using gadoxetic acid-enhanced MRI in transplantation candidates.
    Eur Radiol. 2020 Apr 25. pii: 10.1007/s00330-020-06881.
    >> Share

  245. MAMIDIPALLI A, Fowler KJ, Hamilton G, Wolfson T, et al
    Prospective comparison of longitudinal change in hepatic proton density fat fraction (PDFF) estimated by magnitude-based MRI (MRI-M) and complex-based MRI (MRI-C).
    Eur Radiol. 2020 Apr 21. pii: 10.1007/s00330-020-06858.
    >> Share

  246. DUAN Y, Xie X, Li Q, Mercaldo N, et al
    Differentiation of regenerative nodule, dysplastic nodule, and small hepatocellular carcinoma in cirrhotic patients: a contrast-enhanced ultrasound-based multivariable model analysis.
    Eur Radiol. 2020 Apr 19. pii: 10.1007/s00330-020-06834.
    >> Share

  247. PARK SH, Kim B, Kim SY, Shim YS, et al
    Abbreviated MRI with optional multiphasic CT as an alternative to full-sequence MRI: LI-RADS validation in a HCC-screening cohort.
    Eur Radiol. 2020;30:2302-2311.
    >> Share

    March 2020
  248. LUEDEMANN WM, Geisel D, Gebauer B, Schnapauff D, et al
    Comparing HCC arterial tumour vascularisation on baseline imaging and after lipiodol cTACE: how do estimations of enhancing tumour volumes differ on contrast-enhanced MR and CT?
    Eur Radiol. 2020;30:1601-1608.
    >> Share

  249. REZVANI HABIBABADI R, Khoshpouri P, Ghadimi M, Shaghaghi M, et al
    Comparison between ROI-based and volumetric measurements in quantifying heterogeneity of liver stiffness using MR elastography.
    Eur Radiol. 2020;30:1609-1615.
    >> Share

  250. WITOWSKI J, Budzynski A, Grochowska A, Ballard DH, et al
    Decision-making based on 3D printed models in laparoscopic liver resections with intraoperative ultrasound: a prospective observational study.
    Eur Radiol. 2020;30:1306-1312.
    >> Share

  251. REINERT CP, Sekler J, la Fougere C, Pfannenberg C, et al
    Impact of PET/CT on clinical management in patients with cancer of unknown primary-a PET/CT registry study.
    Eur Radiol. 2020;30:1325-1333.
    >> Share

    February 2020
  252. CHEN J, Wu Z, Xia C, Jiang H, et al
    Noninvasive prediction of HCC with progenitor phenotype based on gadoxetic acid-enhanced MRI.
    Eur Radiol. 2020;30:1232-1242.
    >> Share

  253. CAZZATO RL, De Marini P, Leclerc L, Dalili D, et al
    Large nearly spherical ablation zones are achieved with simultaneous multi-antenna microwave ablation applied to treat liver tumours.
    Eur Radiol. 2020;30:971-975.
    >> Share

  254. LEE JH, Joo I, Kang TW, Paik YH, et al
    Deep learning with ultrasonography: automated classification of liver fibrosis using a deep convolutional neural network.
    Eur Radiol. 2020;30:1264-1273.
    >> Share

  255. LEE S, Kim KW, Jeong WK, Kim MJ, et al
    Gadoxetic acid-enhanced MRI as a predictor of recurrence of HCC after liver transplantation.
    Eur Radiol. 2020;30:987-995.
    >> Share

  256. CASSINOTTO C, Pierredon-Foulongne MA, Belgour A, Delicque J, et al
    Learning curve of liver stiffness measurement using a new hybrid machine composed of transient elastography interfaced with ultrasound.
    Eur Radiol. 2020;30:1088-1095.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016